Investors

Segment Data and Regional Results

Half-Year Financial Report 2026

Segment Data

Segment data — Chemicals

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	3,595	2,502	43.7%	6,257	5,279	18.5%
of which Petrochemicals	2,862	1,857	54.2%	4,918	3,941	24.8%
Intermediates	733	645	13.6%	1,339	1,337	0.1%
EBITDA before special items	377	209	80.3%	610	545	12.0%
Special items in EBITDA	-16	-37	56.5%	-30	-39	22.1%
EBITDA	361	172	109.9%	580	506	14.6%
EBITDA margin before special items (%)	10.5	8.4	.	9.8	10.3	.
Depreciation and amortization^a	310	220	41.1%	595	438	35.8%
EBIT before special items	67	-4	.	16	115	-86.3%
Special items in EBIT	-17	-44	62.5%	-31	-47	35.2%
Income from operations (EBIT)	50	-48	.	-15	68	.
Investments including acquisitions^b	409	519	-21.2%	729	972	-25.1%
Segment cash flow	-356	-176	-101.9%	-848	-567	-49.8%
Assets (June 30)	15,957	13,890	14.9%	15,957	13,890	14.9%
Research and development expenses	21	21	-0.3%	41	41	-1.6%

^aDepreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
^bAdditions to property, plant and equipment and intangible assets

Segment data — Materials

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	3,790	3,240	17.0%	7,028	6,690	5.1%
of which Performance Materials	1,748	1,675	4.4%	3,311	3,413	-3.0%
Monomers	2,042	1,566	30.4%	3,718	3,277	13.5%
EBITDA before special items	792	408	93.9%	1,303	877	48.5%
Special items in EBITDA	-17	-22	24.8%	-32	-32	2.7%
EBITDA	775	386	100.7%	1,271	845	50.4%
EBITDA margin before special items (%)	20.9	12.6	.	18.5	13.1	.
Depreciation and amortization^a	189	225	-15.8%	375	435	-13.9%
EBIT before special items	603	184	227.7%	928	444	108.9%
Special items in EBIT	-17	-22	25.2%	-32	-35	8.8%
Income from operations (EBIT)	586	161	262.9%	897	410	118.8%
Investments including acquisitions^b	178	200	-11.1%	302	335	-9.9%
Segment cash flow	26	256	-89.7%	30	300	-90.0%
Assets (June 30)	10,422	9,770	6.7%	10,422	9,770	6.7%
Research and development expenses	44	47	-5.2%	86	91	-5.6%

^aDepreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
^bAdditions to intangible assets and property, plant and equipment

Segment data — Industrial Solutions

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	2,328	2,160	7.8%	4,420	4,428	-0.2%
of which Dispersions & Resins	1,374	1,240	10.8%	2,572	2,549	0.9%
Performance Chemicals	954	920	3.7%	1,848	1,880	-1.7%
EBITDA before special items	434	307	41.5%	795	668	19.1%
Special items in EBITDA	-44	-8	-422.3%	-55	-14	-279.1%
EBITDA	390	298	30.7%	740	653	13.3%
EBITDA margin before special items (%)	18.6	14.2	.	18.0	15.1	.
Depreciation and amortization^a	148	108	36.3%	243	213	14.2%
EBIT before special items	331	198	67.2%	597	455	31.4%
Special items in EBIT	-89	-9	-951.6%	-101	-15	-590.2%
Income from operations (EBIT)	242	190	27.5%	497	440	12.9%
Investments including acquisitions^b	74	77	-3.1%	144	145	-1.1%
Segment cash flow	-56	224	.	46	366	-87.5%
Assets (June 30)	7,192	6,952	3.4%	7,192	6,952	3.4%
Research and development expenses	45	48	-6.7%	86	94	-8.7%

Segment data — Nutrition & Care

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	1,709	1,618	5.7%	3,378	3,337	1.2%
of which Care Chemicals	1,232	1,190	3.6%	2,455	2,468	-0.5%
Nutrition & Health	477	428	11.4%	923	869	6.2%
EBITDA before special items	204	196	4.2%	396	425	-6.9%
Special items in EBITDA	-9	-7	-16.0%	-17	-11	-56.4%
EBITDA	195	188	3.8%	379	415	-8.6%
EBITDA margin before special items (%)	11.9	12.1	.	11.7	12.7	.
Depreciation and amortization^a	144	137	4.7%	282	262	7.6%
EBIT before special items	60	66	-8.1%	115	172	-33.3%
Special items in EBIT	-9	-15	40.7%	-18	-19	8.3%
Income from operations (EBIT)	52	51	1.3%	97	153	-36.4%
Investments including acquisitions^b	81	157	-48.4%	169	308	-44.9%
Segment cash flow	2	-27	.	-58	-130	54.9%
Assets (June 30)	8,028	7,875	2.0%	8,028	7,875	2.0%
Research and development expenses	30	35	-15.3%	59	69	-14.3%

Segment data — Surface Technologies^a

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	2,625	2,355	11.5%	5,031	4,544	10.7%
of which Battery Materials	174	169	3.0%	309	290	6.4%
ECMS	2,451	2,068	18.5%	4,722	4,026	17.3%
Coatings^b	–	119	-100.0%	–	227	-100.0%
EBITDA before special items	115	172	-33.0%	391	342	14.2%
Special items in EBITDA	-14	-35	61.4%	-17	-45	63.0%
EBITDA	102	137	-25.7%	374	297	25.8%
EBITDA margin before special items (%)	4.4	7.3	.	7.8	7.5	.
Depreciation and amortization^c	50	56	-11.4%	102	113	-10.3%
EBIT before special items	68	119	-42.6%	293	232	26.1%
Special items in EBIT	-16	-38	57.1%	-21	-48	57.1%
Income from operations (EBIT)	52	81	-35.7%	272	184	48.0%
Investments including acquisitions^d	23	30	-21.9%	44	51	-12.8%
Segment cash flow	-28	63	.	120	62	94.3%
Assets (June 30)	6,405	5,851	9.5%	6,405	5,851	9.5%
Research and development expenses	33	40	-17.9%	68	82	-16.6%

^aOwing to the sale of the automotive OEM coatings, automotive refinish coatings and surface treatment businesses to Carlyle, the affected business units were reported as a discontinued operation in accordance with IFRS 5 until the closing of the transaction on June 30, 2026. The previous year’s values have been restated accordingly, even if no retrospective adjustment was made in the balance sheet.
^bThe figures of the Coatings division refer exclusively to the decorative paints business unit, which was sold as of October 1, 2025.
^cDepreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) excluding depreciation and amortization or reversals of impairments attributable to the discontinued Coatings business
^dAdditions to intangible assets and property, plant and equipment, excluding additions attributable to the discontinued coatings business; prior-year figures have been restated

Segment data — Agricultural Solutions

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	2,210	2,198	0.6%	5,315	5,401	-1.6%
of which Fungicides	652	643	1.3%	1,598	1,520	5.1%
Herbicides	836	866	-3.5%	1,707	1,769	-3.5%
Insecticides	250	259	-3.5%	515	543	-5.3%
Seed Treatment	144	111	29.1%	271	257	5.5%
Seeds & Traits	329	319	3.2%	1,224	1,312	-6.7%
EBITDA before special items	448	417	7.5%	1,550	1,621	-4.4%
Special items in EBITDA	-33	-64	48.1%	-57	-79	27.5%
EBITDA	415	353	17.5%	1,493	1,542	-3.2%
EBITDA margin before special items (%)	20.3	19.0	.	29.2	30.0	.
Depreciation and amortization^a	140	144	-3.3%	274	303	-9.5%
EBIT before special items	309	272	13.4%	1,277	1,320	-3.2%
Special items in EBIT	-34	-64	46.9%	-59	-80	26.8%
Income from operations (EBIT)	275	209	31.9%	1,219	1,240	-1.7%
Investments including acquisitions^b	66	70	-4.8%	257	141	81.9%
Segment cash flow	881	811	8.5%	-279	-166	-68.0%
Assets (June 30)	16,361	15,834	3.3%	16,361	15,834	3.3%
Research and development expenses	253	232	9.0%	477	452	5.4%

Financial data — Other^a

Download Excel file

	Q2			H1
Million €	2026	2025	+/-	2026	2025	+/-
Sales to third parties	948	715	32.6%	1,797	1,618	11.1%
EBITDA before special items	80	-114	.	-239	-388	38.4%
of which costs for cross-divisional corporate research	-35	-37	4.2%	-66	-74	10.4%
costs of corporate headquarters	-65	-60	-7.6%	-123	-119	-3.4%
other businesses	59	64	-8.8%	114	90	26.7%
miscellaneous income and expenses	121	-81	.	-164	-285	42.6%
Special items in EBITDA	-352	-98	-258.0%	-446	-478	6.7%
EBITDA	-272	-212	-28.3%	-685	-866	20.9%
Depreciation and amortization^b	48	36	32.0%	83	74	12.8%
EBIT before special items	40	-150	.	-314	-461	32.0%
Special items in EBIT	-360	-99	-265.3%	-455	-479	5.0%
Income from operations (EBIT)	-320	-248	-28.8%	-768	-940	18.2%
Investments including acquisitions^c	25	30	-18.2%	50	64	-22.6%
Assets (June 30)^d	19,502	17,496	11.5%	19,502	17,496	11.5%
Research and development expenses	47	57	-17.9%	92	129	-28.2%

^a The prior-year figures have been restated due to the divestiture of the automotive OEM coatings, automotive refinish coatings and surface treatment business units.
^b Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
^c Additions to intangible assets and property, plant and equipment
^dIncludes assets of businesses recognized under Other and reconciliation to assets of the BASF Group

Regions^a

Million €	Sales by location of company			Sales by location of customer
Q2	2026	2025	+/-	2026	2025	+/-
Europe	7,241	6,138	18.0%	6,870	5,839	17.7%
of which Germany	2,995	2,529	18.4%	1,711	1,489	14.9%
North America	4,467	3,982	12.2%	4,254	3,857	10.3%
Asia Pacific	4,609	3,801	21.3%	4,746	3,856	23.1%
of which Greater China	2,811	2,094	34.3%	2,770	2,102	31.8%
South America, Africa, Middle East	889	867	2.5%	1,336	1,237	8.0%
BASF Group	17,206	14,788	16.4%	17,206	14,788	16.4%

Million €	Sales by location of company			Sales by location of customer
H1	2026	2025	+/-	2026	2025	+/-
Europe	14,125	13,231	6.8%	13,512	12,637	6.9%
of which Germany	5,589	5,311	5.2%	3,254	3,167	2.7%
North America	8,851	8,850	0.0%	8,532	8,563	-0.4%
Asia Pacific	8,626	7,493	15.1%	8,809	7,604	15.8%
of which Greater China	5,339	4,189	27.5%	5,257	4,153	26.6%
South America, Africa, Middle East	1,624	1,722	-5.7%	2,373	2,493	-4.8%
BASF Group	33,226	31,297	6.2%	33,226	31,297	6.2%

^aOwing to the divestiture of the automotive OEM coatings, refinish coatings and surface treatment business units, the sales of these activities were reported as discontinued operations in accordance with IFRS 5 until the closing of the transaction on June 30, 2026 and are no longer included in the sales of the BASF Group.